ReproductiveICD-10: N94.3Up to 75% of menstruating women have some PMS; 3–8% have severe PMDD

Premenstrual Syndrome

Also known as: PMS, Premenstrual Tension

Premenstrual syndrome (PMS) encompasses a wide range of physical, emotional, and behavioral symptoms that occur during the luteal phase of the menstrual cycle (1–2 weeks before menstruation) and resolve shortly after the period begins. Up to 75% of menstruating women experience some PMS symptoms, with about 3–8% meeting criteria for the more severe form, premenstrual dysphoric disorder (PMDD). Symptoms can significantly impair daily functioning in moderate to severe cases.

Last updated October 31, 2026

Understanding Premenstrual Syndrome

Premenstrual syndrome is a predictable cluster of mood and physical symptoms that arrives in the week or two after ovulation and lifts within a few days of bleeding, cycle after cycle. The timing is the whole diagnosis: the same irritability, tearfulness, bloating or breast pain that occurs at random across the month is something else. Most women notice some premenstrual change; PMS is the point where it reliably interferes with work, relationships or sleep, which is true for roughly 20 to 30 percent, and its severe form, premenstrual dysphoric disorder, for 3 to 8 percent. It is not a sign of abnormal hormones. Hormone levels in women with PMS are the same as in women without it.

What differs is the brain's sensitivity to normal hormonal change. After ovulation, progesterone rises and is converted to allopregnanolone, a steroid that acts on the same GABA-A receptors as alcohol and benzodiazepines. In most women it is calming; in women with PMS or PMDD the receptors appear to respond paradoxically, producing anxiety, irritability and low mood as levels climb and then fall. Serotonin signalling also dips in the luteal phase, which is why serotonin-boosting drugs work within days rather than the weeks needed in depression. On the physical side, oestrogen-driven aldosterone and prolactin shifts cause fluid retention and breast tenderness, and prostaglandin release near menstruation brings cramps and headache. Low calcium and magnesium status seem to amplify the whole response.

PMS usually persists until menopause, often worsening in the late thirties and forties as cycles become erratic, and it typically resolves once cycling stops. Conventional care starts with a two-cycle symptom diary to confirm timing. For moderate to severe symptoms, SSRIs such as sertraline and fluoxetine are first-line: a Cochrane review of 31 trials found they reduce symptoms with an odds ratio of about 0.4 for continuous or luteal-phase-only dosing, with nausea and reduced libido the main costs. Combined oral contraceptives, particularly drospirenone-containing pills taken continuously or with a short pill-free interval, suppress ovulation and help many women, though some feel worse on them. Cognitive behavioural therapy matches medication for many. For PMDD unresponsive to these, GnRH analogues with add-back hormones create a chemical ovarian shutdown; surgery is a rare last resort.

Natural approaches sit unusually close to the front line in PMS, because mild and moderate symptoms are common, drugs have trade-offs, and several supplements have randomised evidence. Calcium has the best data of any: 1,200 mg/day for three cycles cut overall symptom scores by 48 percent versus 30 percent on placebo in a 466-woman trial. Chaste tree (vitex) has more than a dozen trials, nearly all positive, though many carry risk of bias; it is the best-supported herb. Vitamin B6 and magnesium each have several small trials with modest effects, and saffron and ginkgo have two or more positive RCTs apiece. St John's wort helped physical symptoms in one crossover trial but interacts seriously with the pill and SSRIs. Evening primrose oil, the most-sold PMS supplement, has consistently failed in controlled trials. For mild to moderate PMS these are reasonable first steps; for PMDD they are adjuncts to SSRIs or hormonal treatment, not substitutes.

The mistake most people make is assuming PMS means a hormone imbalance that a test can find and a supplement can correct. Hormone panels are normal in PMS, so testing is unhelpful, and the useful question is not which hormone is off but how to make the brain less reactive to normal change: steadier sleep, exercise, calcium, serotonin support and, when needed, suppressing ovulation. A symptom diary over two cycles is worth more than any blood test and is what separates PMS from premenstrual worsening of an underlying anxiety or depressive disorder, which needs different treatment.

At a Glance

Common symptoms
Mood swings and irritability, Depressed mood or tearfulness, Anxiety or tension
Main treatments
Regular aerobic exercise (30 minutes most days), Calcium supplementation (1,200 mg/day has evidence for symptom reduction), SSRIs (fluoxetine, sertraline) for severe PMS or PMDD — can be used continuously or only during the luteal phase
Category
Reproductive · Up to 75% of menstruating women have some PMS; 3–8% have severe PMDD
See a doctor if
PMS symptoms that significantly interfere with work, relationships, or daily life

Symptoms

Mood swings and irritability
Depressed mood or tearfulness
Anxiety or tension
Bloating and water retention
Breast tenderness and swelling
Headaches
Food cravings, especially for carbohydrates and sweets
Fatigue and sleep changes
Acne flare-ups
Constipation or diarrhea

Causes

  • Cyclical changes in estrogen and progesterone levels
  • Altered sensitivity to hormonal fluctuations in the brain
  • Changes in serotonin levels during the luteal phase
  • Possible role of GABA and allopregnanolone (progesterone metabolite)

Risk Factors

  • History of depression or mood disorders
  • Family history of PMS or PMDD
  • Age (symptoms often worsen in the late 20s to 40s)
  • Stress
  • Smoking
  • Low physical activity levels

Diagnosis

  • Symptom diary tracking over at least 2 menstrual cycles
  • Symptoms must be present in the luteal phase and resolve within a few days of menstruation
  • Exclusion of other conditions (thyroid disease, depression, perimenopause)
  • PMDD requires ≥5 symptoms with significant functional impairment (DSM-5 criteria)

Treatment

  • Regular aerobic exercise (30 minutes most days)
  • Calcium supplementation (1,200 mg/day has evidence for symptom reduction)
  • SSRIs (fluoxetine, sertraline) for severe PMS or PMDD — can be used continuously or only during the luteal phase
  • Combined oral contraceptive pills (especially drospirenone-containing formulations)
  • Cognitive-behavioral therapy
  • NSAIDs for cramps and headaches

Natural remedies for premenstrual syndrome: what the evidence says

Ranked by the strength of human evidence for premenstrual syndrome specifically. These sit alongside medical care, not in place of it.

  1. In a BMJ-published RCT of 170 women, 20 mg/day of a standardised extract for three cycles produced at least a 50 percent symptom reduction in 52 percent of users versus 24 percent on placebo, with the largest effects on irritability, mood swings, anger, headache and breast fullness. A 2017 meta-analysis of 14 RCTs found vitex beat placebo in nearly every trial and matched fluoxetine in a small head-to-head, though many trials carried high risk of bias.

    Studied dose
    20 to 40 mg/day of a standardised dried fruit extract (such as Ze 440) taken each morning, continuously for at least 3 cycles.
    Cautions
    May interfere with dopamine-acting drugs (bromocriptine, metoclopramide, antipsychotics) and theoretically with hormonal contraceptives, hormone therapy and fertility drugs. Stop if pregnancy is confirmed; avoid with a history of hormone-sensitive cancer.
  2. Calcium

    Strong evidence

    In a multicentre RCT of 466 women, calcium carbonate 1,200 mg/day for three cycles reduced total premenstrual symptom scores by 48 percent compared with 30 percent on placebo, with significant improvements in mood, water retention, food cravings and pain by the third cycle. Smaller trials of 500 to 1,000 mg/day confirmed benefit, and women with PMS have lower luteal-phase calcium and higher parathyroid hormone on average.

    Studied dose
    1,200 mg/day elemental calcium as carbonate or citrate, split into two doses with food, for at least 3 cycles; count dietary calcium toward the total.
    Cautions
    Separate from levothyroxine, iron and tetracycline or quinolone antibiotics by 2 to 4 hours. Avoid exceeding 1,200 mg/day from all sources because of kidney stone and possible cardiovascular signals; safe in pregnancy.
  3. Vitamin B6

    Moderate evidence

    A BMJ systematic review of 9 placebo-controlled trials (940 women) found vitamin B6 at up to 100 mg/day roughly doubled the odds of overall symptom improvement (OR 2.3) and of improvement in premenstrual depressive symptoms (OR 1.7). Trial quality was low and no dose-response was shown, so 50 mg/day appears as good as 100 mg. B6 is a cofactor for making serotonin and dopamine, which fits the luteal-phase serotonin dip.

    Studied dose
    50 to 100 mg/day pyridoxine with food throughout the cycle; do not exceed 100 mg/day.
    Cautions
    Chronic intake above 100 mg/day can cause sensory neuropathy with numbness and tingling that may persist. Lowers the effect of levodopa without carbidopa; safe in pregnancy at ordinary doses.
  4. Magnesium Glycinate

    Moderate evidence

    Small RCTs found 360 mg/day magnesium from mid-cycle reduced mood symptoms over two cycles, 200 mg/day reduced fluid retention and breast tenderness by the second month, and in a 150-woman trial magnesium 250 mg plus vitamin B6 40 mg outperformed either alone. Women with PMS tend to have lower red-cell magnesium. Effects are modest and may take two cycles to appear.

    Studied dose
    250 to 360 mg/day elemental magnesium as glycinate, daily or from cycle day 15 to the start of bleeding, with or without 40 to 50 mg vitamin B6.
    Cautions
    Reduce or avoid with kidney impairment; separate from quinolone and tetracycline antibiotics by 2 hours. Loose stools mean too much; safe in pregnancy at these doses.
  5. Saffron

    Moderate evidence

    In a double-blind RCT of 50 women published in BJOG, saffron 30 mg/day for two cycles produced at least a 50 percent reduction in symptoms in 76 percent of users versus 8 percent on placebo, with large improvements in depressive scores. A later RCT in women with PMDD also found benefit, and saffron has matched fluoxetine and imipramine in depression trials, consistent with a serotonergic mechanism.

    Studied dose
    15 mg of a standardised stigma extract twice daily (30 mg/day), continuously for at least 2 cycles.
    Cautions
    Theoretical additive effect with SSRIs and other serotonergic drugs; mild nausea and appetite change are the usual side effects. Doses above 5 g are toxic, and medicinal doses should be avoided in pregnancy because of uterine-stimulant effects.
  6. Ginkgo

    Moderate evidence

    In a French multicentre RCT of 165 women, standardised ginkgo extract 160 mg/day from day 16 of one cycle to day 5 of the next reduced breast tenderness and neuropsychological symptoms versus placebo. An Iranian RCT of 85 students using 40 mg three times daily on the same schedule found a 23.7 percent fall in overall symptom severity compared with 8.7 percent on placebo. The effect appears strongest for breast pain and fluid symptoms.

    Studied dose
    120 to 160 mg/day of a standardised extract (EGb 761 or equivalent) from cycle day 16 to day 5 of the next cycle.
    Cautions
    Increases bleeding risk with warfarin, DOACs, aspirin and NSAIDs; stop 2 weeks before surgery. May lower the seizure threshold and interact with some antidepressants; avoid in pregnancy.
  7. St. John's Wort

    Preliminary evidence

    In a 36-woman placebo-controlled crossover trial, 900 mg/day of standardised extract for two cycles reduced physical and behavioural premenstrual symptoms, including food cravings, swelling and poor coordination, but did not significantly improve mood, anxiety or pain. An earlier open pilot reported a 51 percent drop in overall scores. The data are mixed and small, and its interaction profile is the main concern.

    Studied dose
    300 mg of extract standardised to 0.3 percent hypericin three times daily (900 mg/day), continuously for at least 2 cycles.
    Cautions
    Induces CYP3A4, reducing the effectiveness of hormonal contraceptives (breakthrough bleeding, contraceptive failure) and lowering levels of many other drugs. Combining with SSRIs, triptans or tramadol risks serotonin syndrome; causes photosensitivity and is not for pregnancy.
  8. Evening Primrose Oil

    Preliminary evidence

    Despite its popularity, a systematic review of the seven placebo-controlled trials concluded evening primrose oil was of little value for PMS, with the two best-designed trials finding no difference from placebo. Doses studied were 3 to 4 g/day for 3 to 6 cycles. A small benefit for cyclical breast pain is possible but inconsistent, and most guidelines no longer recommend it.

    Studied dose
    3 to 4 g/day (about 320 to 480 mg GLA) in divided doses for 3 cycles, if used at all.
    Cautions
    May increase bleeding risk with anticoagulants and lower the seizure threshold with phenothiazines. Generally well tolerated; mild gut upset is the common complaint.

What matters day to day

  • Exercise aerobically for 30 minutes most days: in trials, 8 to 12 weeks of regular aerobic exercise reduced physical and mood symptoms of PMS by roughly a third, comparable to some supplements, likely through endorphin and serotonin effects.
  • Keep a two-cycle symptom diary (an app or the Daily Record of Severity of Problems): it confirms the luteal timing that defines PMS, reveals whether an underlying mood disorder is being unmasked, and lets you judge whether any treatment is really working.
  • Eat complex carbohydrates and regular meals in the luteal phase: carbohydrate-rich meals raise brain tryptophan and improved mood and cravings in a controlled study, while skipping meals worsens irritability.
  • Reduce salt, caffeine and alcohol in the two weeks before your period: salt drives fluid retention and breast swelling, caffeine worsens breast tenderness and anxiety, and alcohol disrupts sleep when it is already fragile.
  • Stop smoking: in the Nurses' Health Study II, current smokers had about a two-fold higher risk of developing moderate to severe PMS over 10 years.

Prevention

  • Regular exercise throughout the menstrual cycle
  • Balanced diet rich in complex carbohydrates, calcium, and magnesium
  • Limiting salt, caffeine, and alcohol in the luteal phase
  • Stress reduction techniques
  • Adequate sleep

When to See a Doctor

  • PMS symptoms that significantly interfere with work, relationships, or daily life
  • Symptoms of PMDD (severe depression, anxiety, or rage premenstrually)
  • Suicidal thoughts related to the menstrual cycle
  • Symptoms that do not improve with lifestyle modifications

Frequently Asked Questions

References

  1. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ (2001)
  2. Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology (2017)
  3. Thys-Jacobs S, Starkey P, Bernstein D, Tian J (Premenstrual Syndrome Study Group). Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. American Journal of Obstetrics and Gynecology (1998)
  4. Wyatt KM, Dimmock PW, Jones PW, O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ (1999)
  5. Agha-Hosseini M, Kashani L, Aleyaseen A, et al.. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG (2008)
  6. Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. CNS Drugs (2010)
  7. Ozgoli G, Selselei EA, Mojab F, Majd HA. A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. Journal of Alternative and Complementary Medicine (2009)
  8. Fathizadeh N, Ebrahimi E, Valiani M, Tavakoli N, Yar MH. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iranian Journal of Nursing and Midwifery Research (2010)
  9. Marjoribanks J, Brown J, O'Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews (2013)
  10. Calcium: fact sheet for health professionals. NIH Office of Dietary SupplementsView source

Related Conditions

Lab tests that relate to premenstrual syndrome

Related from the Supplement Library

These supplements have been studied in relation to Premenstrual Syndrome. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Have questions about Premenstrual Syndrome?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.